Orally Administered Giardia duodenalis Extracts Enhance an Antigen-Specific Antibody Response
AUTOR(ES)
Dunn, Linda A.
FONTE
American Society for Microbiology
RESUMO
We have identified novel adjuvant activity in specific cytosol fractions from trophozoites of Giardia isolate BRIS/95/HEPU/2041 (J. A. Upcroft, P. A. McDonnell, and P. Upcroft, Parasitol. Today, 14:281–284, 1998). Adjuvant activity was demonstrated in the systemic and mucosal compartments when Giardia extract was coadministered orally with antigen to mice. Enhanced antigen-specific serum antibody responses were demonstrated by enzyme-linked immunosorbent assay to be comparable to those generated by the “gold standard,” mucosal adjuvant cholera toxin. A source of adjuvant activity was localized to the cytosolic component of the parasite. Fractionation of the cytosol produced fraction pools, some of which, when coadministered with antigen, stimulated an enhanced antigen-specific serum response. The toxic component of conventional mucosal adjuvants is associated with adjuvant activity; therefore, in a similar way, the toxin-like attributes of BRIS/95/HEPU/2041 may be responsible for its adjuvanticity. Complete characterization of the adjuvant is under way.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=98786Documentos Relacionados
- Messenger RNA for an antigen-specific binding molecule from an antigen-specific T-cell hybrid.
- Antigen-specific cytometry
- Antigen-specific drug-targeting used to manipulate an immune response in vivo.
- Identification of an antigen-specific immunoglobulin M antibody associated with acute Toxoplasma infection.
- Achieving antigen-specific immune regulation
